Given the California state-wide lockdown, we at Scintillon Institute hope you remain calm and aware while doing your best to follow the governor’s directive for blunting the projected jump in infected cases that could potentially overwhelm our medical system. 

We are doing what we can at Scintillon to provide long term help with all issues related to human health and longevity, viral outbreaks included. We plan on conducting the production of cell and possibly vesicle mediated vaccines against SARS-CoV-2.  We also are working on tissue and organ regeneration to help those who have survived a coronavirus infection and developing nanoantibodies that might be used to treat the cytokine storm/septic shock from which some severe-case patients suffer. 

In the meantime, the biomedical research community will continue to work on all diseases to provide cure and comfort. We are happy to report that just today, one of our faculty members, Dr. Jiwu Wang, and his group published a paper in a Nature family journal about how doctors could treat thyroid cancer with more informed choices. 

https://www.todayinnewyork.com/2020/03/20/scintillon-researchers-publish-new-methods-for-thyroid-cancer-prognosis/

Please stay safe and well.  Your continued support of biomedical research is vital because together, we can handle future outbreaks and other health problems better.

Thank you!

Scintillon Institute

The Scintillon Institute Investigator Jiwu Wang and collaborators have published a new publication describing the generation of universal platelets from human induced pluripotent stem cells.

The "A Bright Monomericgreen Fluorescentprotein Derived From Branchiostoma Lanceolatumpublication" was published in Nature Methods (10, 407-209, 2013)

We report a monomeric yellow-green fluorescent protein, mNeonGreen, derived from a tetrameric fluorescent protein from the cephalochordate Branchiostoma lanceolatum.

The Scintillon Institute's first publication, "Feeder-Free Derivation of Human Induced Pluripotent Stem Cells with Messenger RNA," by Jiwu Wang has been published in the new Nature family journal Scientific Reports.

The therapeutic promise of induced pluripotent stem cells (iPSCs) has spurred efforts to circumvent genome alteration when reprogramming somatic cells to pluripotency.  Our mRNA method uniquely affords unprecedented control over reprogramming factor (RF) expression while obviating a cleanup phase to purge residual traces of vector.